senktide has been researched along with oxidopamine in 6 studies
Studies (senktide) | Trials (senktide) | Recent Studies (post-2010) (senktide) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
---|---|---|---|---|---|
292 | 1 | 50 | 8,630 | 6 | 2,407 |
Protein | Taxonomy | senktide (IC50) | oxidopamine (IC50) |
---|---|---|---|
Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dourish, CT; Iversen, SD; Stoessl, AJ | 1 |
Alberch, J; Arenas, E; Marsal, J; Pérez-Navarro, E | 1 |
Stoessl, AJ | 1 |
Glowinski, J; Godeheu, G; Kemel, ML; Pérez, S; Soubrié, P | 1 |
Andren, PE; Chergui, K; Svenningsson, P; Zhang, X | 1 |
Chao, OY; de Souza Silva, MA; Nikolaus, S; Wang, AL | 1 |
6 other study(ies) available for senktide and oxidopamine
Article | Year |
---|---|
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
Topics: Animals; Brain Chemistry; Dose-Response Relationship, Drug; Haloperidol; Hydroxydopamines; Injections, Subcutaneous; Male; Oxidopamine; Parasympathetic Nervous System; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Tachykinin; Scopolamine; Stereotyped Behavior; Substance P; Yawning | 1988 |
Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons.
Topics: Acetylcholine; Animals; Benzazepines; Clozapine; Dopamine; Dopamine Agents; Haloperidol; In Vitro Techniques; Male; Neostriatum; Neurons; Oxidopamine; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Substance P; Tachykinins | 1993 |
Localization of striatal and nigral tachykinin receptors in the rat.
Topics: Animals; Autoradiography; Corpus Striatum; Male; Mazindol; Medial Forebrain Bundle; Oxidopamine; Peptide Fragments; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, Tachykinin; Substance P; Substantia Nigra; Tissue Distribution | 1994 |
Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum.
Topics: Acetylcholine; Animals; Benzamides; Corpus Striatum; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; In Vitro Techniques; Male; N-Methylaspartate; Neural Inhibition; Neurons; Oxidopamine; Peptide Fragments; Piperidines; Pyrrolidonecarboxylic Acid; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Tachykinin; Substance P; Synaptic Transmission; Tachykinins; Time Factors | 2002 |
Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cocaine; Disease Models, Animal; Dopamine; Feedback; Functional Laterality; Gene Expression Regulation; Levodopa; Oxidopamine; Parkinson Disease; Peptide Fragments; Quinolines; Radioisotopes; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Serine; Substance P; Sympatholytics; Tyrosine 3-Monooxygenase | 2008 |
NK₃ receptor agonism reinstates temporal order memory in the hemiparkinsonian rat.
Topics: Animals; Male; Medial Forebrain Bundle; Memory; Movement; Neuropsychological Tests; Nootropic Agents; Oxidopamine; Parkinsonian Disorders; Peptide Fragments; Random Allocation; Rats, Wistar; Receptors, Neurokinin-3; Substance P; Time Perception | 2015 |